Operating Lease, Right-of-Use Asset of Verve Therapeutics, Inc. from 31 Dec 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verve Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
  • Verve Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $76,217,000, a 8.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Verve Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $76,217,000 -$7,310,000 -8.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $78,082,000 -$7,213,000 -8.5% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 $79,921,000 -$7,120,000 -8.2% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $81,736,000 -$7,030,000 -7.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $83,527,000 -$6,476,000 -7.2% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $85,295,000 -$6,582,000 -7.2% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $87,041,000 -$4,291,000 -4.7% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $88,766,000 +$87,927,000 +10480% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $90,003,000 +$88,663,000 +6617% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $91,877,000 +$90,038,000 +4896% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $91,332,000 +$88,997,000 +3811% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $839,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,340,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,839,000 +$1,839,000 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $2,335,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q4 2020 $0 31 Dec 2020 10-K 14 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.